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Using the Years-of-Healthy-Life Measure
to Calculate QALYs
Peter A. Muennig, MD, MPH, Marthe R. Gold, MD, MPH
Background: The quality-adjusted life year (QALY) is an attractive outcome measure because it captures
both health-related quality of life (HRQL) and life expectancy in a single metric. We
present a method for calculating QALYs that is simple, utilizes data that are free of charge,
and may improve consistency in burden-of-disease investigations.
Methods: For purposes of illustration, we calculated the burden of disease due to stroke using two
abridged life tables, each adjusted for HRQL. The first life table was generated using
all-cause mortality and morbidity data (a reference cohort) and the second was generated
using all diseases except stroke (a stroke-free cohort). The difference in total QALYs and
in quality-adjusted life expectancy (QALE) was determined by subtraction.
Results: Approximately 61,328 (95% CI560,272, 62,383) QALYs were lost to stroke in the life-table
cohort. Stroke is responsible for a decrement of 0.03 years of life expectancy and 0.61 years
of QALE in the United States.
Conclusions: The “years of health life”measure affords a rapid, inexpensive, and sensitive means for
estimating the burden of disease for local health priorities and may assist research efforts
in including QALYs as an outcome measure.
Medical Subject Headings (MeSH): cost-benefit analysis, health status, health status indicators,
population characteristics, quality-adjusted life years (Am J Prev Med 2001;20(1):35–39)
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Introduction
Because the quality-adjusted life year (QALY) cancapture both health-related quality of life(HRQL) and life expectancy in a single metric, it
is an attractive outcome measure for cost-effectiveness
analyses and burden-of-disease calculations.1 However,
since calculating QALYs may be complicated, expen-
sive, and time consuming,2 some investigators may be
reluctant to include them in their research. This may
be especially true when limited funding is available with
which to conduct a study or when rapid burden-of-
disease assessments are needed. Moreover, burden-of-
disease estimates may not be comparable when differ-
ent data sources are used and may not fully capture
comorbid illness or disability when data are limited.
Techniques that permit ready calculation of QALYs
using comprehensive data are therefore helpful to
investigations intended to support public health agency
resource allocation decisions under conditions of
uncertainty.
The National Health Interview Survey (NHIS) is an
annual survey of the U.S. population containing self-
reported illness, role function, and perceived health
status. A QALY-compatible research tool, the “years of
healthy life” (YHL) measure has been used to generate
a simple “off-the-shelf” list of HRQL scores for the
calculation of quality-adjusted life expectancy (QALE)
in the United States using mortality data and data from
the NHIS.3–5 The National Center for Health Statistics
(NCHS) has created a matrix of 30 possible HRQL
values by combining five levels of self-reported health
and six levels of role function and linking these states to
a multiattribute utility model, described in detail by
Erickson et al.4 The HRQL values for the different cells
have been linked to self-reported conditions.5 Though
these data may be limited by the use of only two
dimensions of HRQL and self-report bias, it is possible
to adjust these parameters for demographic factors and
to thereby capture the average HRQL of specific
populations.5,6
Given that the NHIS data may be combined with
mortality data that are simple to access and use, devel-
oping a means of using the YHL measure to calculate
both QALYs and QALE may shorten the time to com-
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plete economic analyses and burden-of-disease studies
while reducing the cost and improving the specificity of
the analysis. Moreover, since documents compiled by
the NCHS, the organization that produces both the
mortality data and NHIS data, are free of charge and
available on the Internet, it may be possible to conduct
burden-of-disease studies and cost-effectiveness analy-
ses with minimal overhead.
In this paper, we explore a simple means of calculat-
ing QALYs using publicly available NHIS and mortality
data available from the NCHS.4,5,7–9
Methods
Overview
To illustrate the use of the YHL measure for the calculation of
QALYs and QALE, we calculated the burden-of-disease due to
stroke. We first calculated quality-adjusted person-years re-
maining at birth in an abridged life table cohort using the
methods forwarded by Erickson et al.4,7,8 (Table 1.) This
cohort serves as a reference against which marginal QALYs
due to stroke may be calculated. We then generated a second
abridged life table in which the cohort is subjected to the risk
of dying from all diseases but stroke (a “stroke-free” cohort).
Finally, we subtracted the quality-adjusted person-years re-
maining at birth in the reference life table cohort from the
quality-adjusted person-years remaining at birth in the stroke-
free cohort. All calculations were conducted using abridged
life tables on Excel 98 for the Macintosh (Microsoft Inc.
Redmond, WA).
Reference Cohort
An abridged life table is constructed using a hypothetical
population in which 100,000 people are born each year. It is
assumed that all people in this cohort are at risk of dying or
becoming ill, but that there is no migration into or out of the
population. Because 100,000 people are born into the cohort
each year, the number of persons in the cohort is equal to the
number of person-years in the cohort.7,8 When person-years
are adjusted for HRQL, they become QALYs. Table 1 illus-
trates how a life table is constructed using the YHL measure
to determine the number of QALYs in a cohort.
Use of Published Data
With reference to Table 1, Column 1 represents the proba-
bility of death in a given interval; Column 2, the number of
people alive at the beginning of the age interval; and Column
3, the number of persons dying during the interval. Using
data from an abridged life table, Column-3 values for each
interval are entered first.7 Column-2 values are calculated as
sx5sx-12dx21, where sx is the number of survivors at the
beginning of age interval x, dx is the number of persons dying
in the interval, and x21 denotes the previous interval.
Because all life tables begin with 100,000 persons alive at the
beginning of the first age interval, the first value of Column 2
is 100,000. Dividing the total number of deaths in the interval
(Column 3) by the number of persons alive at the beginning
of the interval (Column 2), yields the probability of death
during the interval (Column 1).
Column 4 row values represent the total number of person-
years in the interval and are calculated using the formula
n(sx20.5dx), where n is the length of the interval. This
formula assumes that all deaths occurred at the midpoint of
the interval—an assumption that does not hold for the first
year of life (because of infant mortality) or the last age
interval (because the interval is of indeterminate length).
The number of person-years in the first year of life is
calculated as 100,000f1(12f)s1, where f is the separation
factor8 and s1 is equal to the number of persons surviving to
age 1. The separation factor is equal to the proportion of
infant deaths in the base year occurring to infants born the
previous year and is available from the NCHS8 and s1 may be
obtained directly from an existing life table.7,8 The number of
person-years in the first age interval in Table 1 is thus
(n21)(sx20.5dx)1s0f1(12f)s1,7 where dx is the number of
deaths occurring in persons aged 1 to 44. The probability of
death for the $75 age interval is equal to the reciprocal of the
life expectancy at age 75.
To obtain cumulative person-years (Column 5) the values
for Column 4 are summed backwards such that the value for
the first age interval is equal to the sum of all values in
Column 4. Each row in Column 6 is calculated by dividing the
row value of Column 5 by the corresponding row value for
Column 2. The value of the first row in Column 6 is equal to
the life expectancy at birth of the cohort and serves to validate
the spreadsheet (this should be similar to the life expectancy
at birth in abridged life tables). The values in Column 7
represent the HRQL score for the average person in the
United States in each corresponding age interval and are
available from the NCHS.4 Column 8 is equal to the product
of Column 7 and Column 4. Columns 9 and 10 are derived in
a manner analogous to Columns 4 and 5.
Since the age intervals must be the same across prevalence,
mortality, and HRQL data, it is best to generate age intervals
Table 1. QALY and QALE in the reference life table cohort
Age
interval


















,45 0.050 100,000 5,004 4,405,191 7,601,026 76.0 0.91 4,019,648 6,449,217 64.5
45–64 0.142 94,996 13,486 1,765,060 3,195,834 33.6 0.82 1,445,507 2,429,570 25.6
65–74 0.225 81,510 18,348 723,360 1,430,774 17.6 0.75 543,005 984,063 12.1
751 1.000 63,162 63,162 707,414 707,414 11.2 0.62 441,058 441,058 7.0
aAverage HRQL for persons in age interval.
HRQL, health-related quality of life; QALE, quality-adjusted life expectancy; QALYs, quality-adjusted life years
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common to all available data. When using estimates of disease
prevalence published by the NCHS, it is easiest to use the four
intervals presented in Table 1 (although the use of electronic
NHIS data obviates this requirement). Alternatively, the 0 to
45 year interval may be broken into two separate intervals, 0
to 15 and 15 to 44, producing a total of five age intervals. In
doing so, the researcher assumes that the disease prevalence
ratio for persons aged 15 to 44 (the interval used in mortality
publications) is equal to the prevalence ratio for persons aged
18 to 44 (the interval used to report prevalence ratios).
Use of Electronic Data
Although the use of electronic data substantially increases the
cost and time requirements of cost-effectiveness or burden-
of-disease studies, it is possible to use much smaller age
intervals, and thus improve the accuracy of model outputs. To
generate reliable prevalence and HRQL estimates using elec-
tronic data, it is necessary to aggregate 3 to 4 years of NHIS
data.
The first row value for Column 1 (q0) is approximated
using the infant mortality rate, which is equal to the number
of deaths in the first year of life divided by the number of live
births. Because some deaths occur in infants born the previ-
ous year and the number of live births varies slightly from year
to year, a more accurate estimate may be obtained using the
separation factor, f. The more accurate estimator of q0 is
D0(12f)/Bx1D0f/Bx21, where D0 is the total number of
infant deaths and Bx is the total number of births in year x.
The remaining values for Column 1 are generated using
the formula qx5Dx/(Px10.5Dx) where qx is the probability of
death during the interval, Dx is the total number of deaths
observed at age x, and Px is the midyear population for
persons aged x.8 The survivors at age x (sx) may then be
calculated as sx21(12qx-1). Column 3 values are simply the
product of Columns 1 and 2 values for the corresponding
rows.
All other values are calculated in an identical manner to
those derived from a published life table, with the exception
of total person-years in the final age interval. This is equal to
the number living at the beginning of the interval divided by
the probability of death during the interval (sx/qx).
Stroke-Free Cohort
Table 2 represents an abridged life table for all persons
except those with cerebrovascular disease listed as an under-
lying cause of death (International Classification for Disease,
9th Revision codes 430 to 438). Table 2 is calculated in the
same manner as Table 1 with a few exceptions. In Column 1,
the probability of death in the interval due to the disease
under study (in this case, stroke) is subtracted from the
all-cause mortality rate.
Column 5 contains age-specific prevalence rates for the
disease under study.9 These are multiplied by (12HRQL) for
the disease in question (in this case, the age-specific YHL
score for stroke)5 in Column 6. The product of Columns 5
and 6 for each age interval is then added to the average
HRQL (Column 7). This is mathematically equivalent to
averaging out the HRQL lost to stroke in the cohort. The
remainder of Table 2 is calculated in a manner analogous to
Table 1.
Finally, we calculated the burden of disease due to stroke by
subtracting QALYs remaining in the cohort with all diseases
(see Table 1, Column 9, Row 1) from QALYs remaining in the
cohort with all diseases except stroke (see Table 2, Column 9,
Row 1). To obtain the QALE lost to stroke, the QALE in the
reference cohort (see Table 1, Column 10, Row 1) is sub-
tracted from the QALE in the stroke-free cohort (see Table 2,
Column 10, Row 1). We validated the spreadsheet model by
comparing our QALE value with published reports.
Sensitivity Analysis
Of the two data sets used to calculate QALYs, only the NHIS
data are subject to random error. Since the NHIS is used to
generate both HRQL scores and disease prevalence rates, it is
possible to calculate the standard error for these parameters.9
A discussion of random and nonrandom errors may obtained
from the NCHS.9
Although it is possible to estimate the standard error of
HRQL scores obtained from the YHL measure, the standard
error provides no information about the degree to which the
scores represent the preferences of particular subgroups for
the conditions specified. We have noted previously that the
scores are developed from a two-domain model, which nec-
essarily represents a relatively coarse description of a health
state. In addition, scores are calculated rather than measured.
Finally, the structure of the NHIS does not allow comorbidi-
ties to be broken out separately.5 For all of these reasons,
investigators may wish to conduct sensitivity analyses for the
HRQL values by using 25th and 75th percentile values for the
conditions studied. These values have been previously pub-
lished and are available in tabular form.5 The extent to which
death certificate data are subject to misclassification bias or
other types of nonrandom error may be estimated from the
Table 2. QALY and QALE in an abridged life table cohort for persons without stroke
Age
interval















,45 0.050 5,002 4,405,283 76.0 0.0017 0.62 0.913 4,024,338 6,510,545 65.11
45–64 0.142 13,460 1,765,369 33.7 0.0149 0.47 0.825 1,458,123 2,486,208 26.17
65–74 0.224 18,238 724,195 17.6 0.0519 0.43 0.772 559,793 1,028,085 12.61
751 1.000 63,300 708,964 11.2 0.988 0.38 0.660 468,291 468,291 7.40
aHRQL score associated with the YHL measure.
HRQL, health-related quality of life; QALE, quality-adjusted life expectancy; QALYs, quality-adjusted life years; YHL, years of healthy life
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medical literature10–12 and sensitivity analyses conducted, as
appropriate.
Results
Life expectancy, QALE, and QALYs remaining at birth
for the general U.S. population cohort and the stroke-
free cohort are presented in Table 3. The burden of
disease due to stroke was approximately 61,328 QALYs.
Assuming that a negligible number of deaths due to
stroke would be attributed to other causes and that the
years of healthy life measure produces HRQL scores
that are representative of the condition-specific values
of the general U.S. population, the 95% confidence
interval for the burden of disease due to stroke in our
life table cohort would be approximately 60,272 QALYs
to 62,383 age-adjusted QALYs. If stroke were elimi-
nated, persons in the United States would gain approx-
imately 0.61 years of QALE but only approximately 0.03
years of additional life.
The reference cohort produced a QALE at birth of
64.5 years—0.5 years longer than the 1990 NCHS
estimate of QALE, 64 years.4 Our estimate of life
expectancy in 1997, 76 years, differed from the NCHS
estimate, 76.5 years, by approximately seven tenths a
percent—a variation that is likely attributable to the
large age intervals used in this study.
Conclusions
In this paper, we illustrated a simple technique for
calculating QALYs using data accessible by the Internet.
To illustrate this method, we calculated QALYs lost to
stroke in our cohort, an estimate affected by random
error. The model predicted the loss of approximately
61,328 QALYs to stroke in the hypothetical life-table
cohort. On average, persons residing in the United
States could expect to live approximately 0.61 addi-
tional years of quality-adjusted life if strokes were
eliminated, but only approximately 0.03 additional
years of life when quality adjustments are not included.
The difference between absolute and quality-adjusted
years gained underscores the importance of including a
valuation of quality years lost to morbidity. This method
not only allows for rapid tabulation of the burden of
disease due to most illnesses, but it also provides a
convenient way of calculating the number of QALYs
gained due to an intervention in cost-effectiveness
analyses.
For researchers wishing to conduct a cost-effective-
ness analysis, the differential in QALE for a group with
and without a condition will usually provide sufficient
data for the construction of a decision analysis model.1
Moreover, most interventions will not require de novo
generation of HRQL scores using data from the NHIS
since these data are readily available in the medical
literature.4,5
Calculations for the YHL measure are based on the
technique of correspondence analysis13 which is linked
to values drawn from the Health Utilities Index
(HUI),14 a relatively complex, multi-attribute, health
status instrument. Multi-attribute models typically uti-
lize multiple health domains. Given its two-domain
structure (role function and self-reported health),
HRQL scores derived from the YHL measure may be
less precise than scores generated from measures that
have a more complex formulation of health such as the
HUI, the Quality of Well-Being Index,15 and the Euro-
Qol.16 On the other hand, the measure’s ability to
include the average HRQL of a population and to
generate HRQL scores specific to a demographically
defined group may provide advantages over other
HRQL indexes in particular settings. Ideally, future
population surveys would contain more complex pref-
erence-based instruments that could be coupled to
specific disease prevalence data.
The NHIS is an annual survey conducted by the
NCHS.17 Data are collected in face-to-face interviews in
a nationally representative sample of households.
When conducting our sensitivity analysis, we only in-
cluded sources of random error in estimating the 95%
confidence interval for the burden of disease due to
stroke. There is debate surrounding the sensitivity and
specificity of self-report data which are subject to recall
bias.18,19 A subject’s inability to accurately remember
the illnesses from which he or she suffers may affect
both the tabulation of prevalence rates and the HRQL
score. Moreover, the use of death certificates to ascer-
tain mortality rates is subject to misclassification bi-
as.10–12 Death certificates may fail to correctly classify




cohort Difference 95% CI**
Life expectancy 76.01 76.04 0.03 –
QALE 64.49 65.11 0.61* 0.60–0.61
QALY 6,449,217 6,510,545 61,328 60,272–62,383
*Difference is not exact due to rounding.
**Based on sampling error in prevalence estimate alone.
QALE, quality-adjusted life expectancy; QALY, quality-adjusted life years.
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the primary or underlying cause of death or the demo-
graphic characteristics of the decedents.
Because the sample size of the NHIS is small (approx-
imately 103,000 people in 1997),15 relative to the total
number of possible diseases subjects might be afflicted
with, the researcher often faces a trade-off between
unreasonably large age intervals or too few subjects to
generate reliable estimates of prevalence or HRQL.
Although African Americans and Hispanics are over-
sampled in the NHIS, researchers interested in obtain-
ing prevalence rates for other races/ethnicities or for
specific geographic regions will not likely be able to
generate reliable estimates using a single year of NHIS
data. Sample size issues may be overcome by aggregat-
ing NHIS data over a number of years.5 However,
year-to-year changes in disease prevalence may limit
this method. Finally, the age intervals we used were
broad. When infant mortality is accounted for sepa-
rately, however, the use of the broad age intervals we
present here only produces a slight underestimate of
life expectancy (data not shown).
The Panel on Cost-Effectiveness in Health and Med-
icine1 recommends that cost-effectiveness analyses de-
signed to inform resource allocation decisions should
present outcomes in the form of QALYs. The method
we present for calculating QALYs is simple enough to
permit their use in resource-limited research efforts.
Using the techniques discussed in this paper, it is
possible for public health researchers to generate bur-
den-of-disease estimates specific to demographically
defined communities within the span of a few hours.
This method may, therefore, also have great utility in
assisting public health agencies in making rapid deci-
sions surrounding the allocation of resources to local
health priorities.
We are indebted to Marianne Fahs, Clyde Schecter, Peter
Franks, and Karla Hansen for their assistance with verifying
the statistical accuracy of the calculations in this paper.
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